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ABSTRACT 
 
 Cytokines have been shown to cause a reduction in nerve conduction when 
examined using animal models. Such effects, if shown in humans, could result in 
detrimental effects to physical function during periods heightened systemic cytokine 
concentrations. The study investigated the acute effects of cytokines on nerve conduction 
velocity (NCV) and functional measures. Measures were taken under both basal and 
elevated cytokine concentrations to determine any corresponding changes to NCV. A 
significant positive correlation was found between the cytokine IL-6 and NCV at 2 hours 
post-exercise (r=0.606, p=0.048). A significant negative correlation was found between 
IL-1ra and NCV at 24 hours post-exercise (r=-0.652, p=0.021). A significant positive 
correlation was also found between IL-1ra and endurance at 1 hour post-exercise 
(r=0.643, p=0.033). As such, it would seem that IL-6 may potentially act to enhance 
nerve function while other cytokines such as IL-1ra may have negative effects and reduce 
NCV.  
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I. INTRODUCTION 
 
Following spinal cord injury (SCI), individuals typically regard the immediate 
motor and sensory losses as the largest area of concern. Loss of function below the level 
of the lesion produces numerous obstacles making the performance of activities of daily 
living and the maintenance of an independent lifestyle an arduous task. Unfortunately, the 
immediate functional consequences inflicting individuals following SCI are not the only 
issues which impact life post-injury. Numerous secondary health complications are quite 
common, arising due to factors such as inactivity, disuse of muscle groups below the 
lesion, and loss of sensation necessary in the detection of arising health issues. In turn, 
complications including, cardiovascular disease, muscular atrophy, urinary tract 
infections, and pressure sores are not uncommon among this population. The role a loss 
of function plays in the development of many secondary health complications is quite 
clear, however, it is now becoming more evident that many of these secondary health 
complications may in turn, indirectly affect function. 
 The presence of a chronic elevation in systemic cytokine concentrations has been 
shown to occur following trauma to the spinal cord. This chronic elevation is apparent 
despite a lack of any secondary health complications capable of inducing an 
inflammatory response. When these common health complications do arise, a resulting 
acute spike in cytokines occurs (Davies et al., 2007). As such, cytokines typically remain 
in a chronically elevated state following SCI with greatly exaggerated elevations during 
periods of acute inflammation. As pro-inflammatory cytokines play an important role in 
the inflammatory response and therefore help to aid in tissue repair, their elevation would 
be seemingly beneficial regarding the potential repair of damaged spinal tissue. The 
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presence of elevated cytokine concentrations has however been shown to be related to 
conduction deficits due to a phenomenon known as channelopathy. Such effects were 
shown in a study by Davies et al. (2006), in which the effects of tumour necrosis factor-α 
on the electrophysiological properties of an excised guinea pig spinal cord were 
examined. It was shown that elevations in the cytokine led to axonal conduction deficits, 
as shown by a reduction in compound action potential amplitude and a depolarization of 
resting membrane potential. If these same channelopathic effects were to occur in vivo, 
within human subjects, then cytokines, among other molecules, would have the ability to 
cause further detriments concerning the motor and sensory capabilities of individuals 
with spinal cord injuries. These effects would be of particular interest concerning 
individuals with some amount of spared neural tissue at the level of the lesion.    
A SCI may result in the maintenance of the structural integrity of a number of 
spinal tracts, with a preservation of partial motor and sensory function. However, despite 
the fact that certain tracts remain structurally healthy, conduction deficits may still occur 
due to alterations in ion kinetics. Cytokines may disrupt signal conduction by interfering 
with the exchange of sodium (Na+) and potassium (K+) ions across the cell membrane. 
Through the blockage Na+ and K+ channels, a resulting disruption in membrane potential 
may lead to the reduction or even complete abolishment of signals. Individuals with SCI 
may therefore not be achieving their true motor and sensory capabilities as structurally 
healthy tracts may be unable to function as such.  
If cytokines due in fact contribute to channelopathy then future considerations 
examining methods of controlling systemic levels or preventing the clogging of ion 
channels may help to enhance both the motor and sensory capabilities of individuals with 
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SCI. The purpose of the present study is to investigate the acute effects of elevated 
systemic cytokine concentrations on peripheral nerve function in vivo, in human subjects.      
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II. REVIEW OF LITERATURE  
2.1.0 Background and Epidemiology of Spinal Cord Injury 
2.1.1 Anatomy of the Spinal Cord  
The spinal cord provides a pivotal conduit between the brain and body in which 
all motor and sensory information travels. Ascending tracts carry sensory information 
such as touch, temperature, pain, and joint position to the brain whereas descending tracts 
carry motor signals to muscle groups throughout the body to initiate movement. The 
spinal cord is composed of outer spinal tracts known as white matter, and an inner 
segment comprised of neuronal cell bodies and interneurons known as grey matter. 
Contained within the protective sheath of the vertebral column, and surrounded by a 
cushion of cerebral spinal fluid, the delicate tissue of the spinal cord relays critical signals 
to the limbs, trunk, and organs. These signals exit and enter the spinal cord via small 
spinal roots which branch out through spaces known as foramina within the vertebral 
column. These roots then travel to their target tissue and innervate them by means of 
neurotransmitter release.   
2.1.2 Innervation of the Spinal Cord  
The spinal cord is categorized into five regions, each of which is further divided 
into a number of segments. Each spinal segment is responsible for innervating a unique 
muscle group or organ as well as receiving sensory information from a particular region 
of the body. Groups of muscles receiving innervation from a specific spinal segment are 
known as myotomes. A single spinal segment typically innervates more than one 
myotome, just as most muscle groups are innervated by more than one spinal segment. 
This overlap may have important functional implications concerning damage to the spinal 
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cord. If a particular region of the spinal cord is to become damaged, resulting in loss of 
innervation to the myotome, partial innervations may still be possible from a more rostral 
segment. This allows for the partial preservation of motor abilities to that muscle group. 
Specific areas of the skin responsible for relaying sensory information to particular areas 
of the spinal cord are termed dermatomes. Unlike myotomes however, dermatomes 
generally provide information to only one spinal segment. Due to the complex overlaying 
innervations in addition to varying levels, severities, and the specific location of damage 
to the motor neuron, spinal cord injuries (SCI) are highly variable and often differ greatly 
from one individual to the next. 
2.1.3 Epidemiology and Demographics of SCI  
The incidence rate of SCI in North America has been on the rise over the past 
thirty years and currently stands at 35 and 40 per million population per year in Canada 
and the United states respectively (Kattail et al., 2009). Of these individuals, an estimated 
55% have incomplete SCI, meaning some degree of motor and/or sensory capabilities are 
maintained below the lesion. In regards to the level of the SCI, those to the cervical 
region are the most common, accounting for approximately 51% of all cases. Lower level 
SCI such as those affecting the thoracic and lumbar region are less common accounting 
for 21 and 28% respectively (Lenehan, et al., 2009).  
The mean age of individuals living with SCI has traditionally been quite young at 
approximately 32 years of age. However, over the past thirty years an increase in the 
number of older adults living with SCI has become evident, due in part to advancements 
in treatment and care. In 2001, Sekhon and Fehlings reported an increase in SCI 
occurring in older adults from 4.7% in the 1970’s to 10% in 2001. The mean age in North 
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America is now approximated at 42.2 years of age (Pickett et al., 2006). Despite the shift 
in the mean age of individuals living with SCI, when concerning the age of onset, young 
males are still deemed to be at the highest risk and outnumber females by a ratio of 3:1 
(Dryden et al., 2003).   
2.1.4 Etiology and SCI  
Etiological data suggests that the primary cause of SCI in North America is motor 
vehicle accidents, accounting for approximately 50% of all cases (Chester et al., 2007). 
This includes injuries sustained to the driver or passenger of a vehicle as well as to those 
hit by vehicles. Falls are regarded as the second most common cause accounting for 
approximately 24% of all cases. Although SCI caused by falls are only half as common 
as motor vehicle accidents, they are the only cause which has steadily increased over the 
past 30 years. Sports related injuries have shown a decline over the past 3 decades and 
are now responsible for only 9% of injuries. Lastly, injuries caused by violence showed a 
steady increase, until peaking in the mid 1990’s, however, they have since declined to an 
estimated 11.2%.       
 Based on an estimated prevalence of 755 per million population, approximately 
250 000 people are currently living with a SCI in North America (Wyndaele & 
Wyndaele, 2006). This creates a need for further research and new treatment methods to 
help alleviate the physiological, psychological, and socioeconomic impact placed on 
individuals with SCI. As the location and severity of a SCI are highly variable from one 
individual to the next, no two injuries are ever exactly the same. Therefore, the 
development of treatment methods which can be individualized for each patient’s unique 
pathology is of extreme importance.      
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2.1.5 Injury Level  
 The level of spinal tissue damage will vary depending on the nature of the 
accident or disease and may affect one spinal segment or span over several segments. As 
each segment of the spinal cord is responsible for innervating a particular myotome and 
receiving information from a particular dermatome, the level of the injury will dictate the 
diagnosis of either tetraplegia or paraplegia. Tetraplegia refers to the loss or impairment 
of motor and/or sensory function due to a lesion in the cervical region of the spinal cord. 
As an injury to the cervical region is a high level injury, innervations to the upper 
extremities, in addition to the lower extremities, trunk, and pelvic organs will all be 
affected.  Paraplegia refers to the loss or impairment of motor and/sensory function due 
to a lesion in the thoracic, lumbar, or sacral region. Due to the relatively lower level of 
the injury, the upper extremities remain unaffected while the degree to which the lower 
extremities, trunk and pelvic organs are affected vary depending on the specific spinal 
segment affected.   
2.1.7 Severity   
A SCI may widely vary in severity or the completeness of the injury. A complete 
injury is one in which there is no sensory or motor function at some point below the level 
of the lesion. However, with less severe injuries there is a greater sparing of neural tissue 
and improved functional outcome. Such injuries are termed incomplete and the potential 
for the exchange of some sensory and/or motor information remains. The completeness 
of an injury is determined by the presence or absence of motor and sensory capabilities in 
the fourth and fifth sacral regions of the spinal cord. If any amount of sensory or motor 
ability exists, the injury is deemed incomplete. This classification can be further specified 
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by considering the amount of motor and sensory capabilities preserved following SCI. By 
means of the American Spinal Injury Association (ASIA) impairment scale (AIS) an 
individual’s motor and sensory function can be evaluated based on a 5 tier scale. The 
scale ranges from AIS-A, denoting a complete injury, to AIS-E, signifying the individual 
has normal motor and sensory capabilities. A grade of B, C, or D, indicates an incomplete 
injury and specifies the degree to which motor and sensory capabilities are maintained 
(see appendix for precise definition of each classification).         
2.1.8 Dyscomplete SCI 
 In certain cases, a SCI may be classified as complete despite the preservation of 
the structural integrity of a number of spinal tracts. In situations such as these, the spinal 
cord will have a structural appearance much like that of an incomplete injury and the 
preservation of partial motor and sensory function below the level of the lesion would be 
expected. The fact that there is an absence of function below the lesion, (specifically in 
the 4
th
 and 5
th
 sacral regions) despite a lack of structural damage to all tracts, suggests 
that a non-structurally based mechanism must be responsible for the apparent conduction 
deficits. It has been theorized that molecules seen at high levels during periods of 
physiological or psychological stress may be responsible. As SCI is typically 
characterized by high levels of each of these stressors, an elevation in stress induced 
molecules such as, antibodies, toxins, and cytokines may be expected.    
2.2.0 Cytokines and Immunoregulatory Function  
2.2.1 Cytokine Production  
Cytokines are small signaling proteins involved in an array of immunoregulatory 
responses including hematopoiesis, and inflammation (Sredni-Kenigsbuch, 2002). 
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Historically, they have been viewed solely as molecules produced and released by a 
variety of immune cells in response to an immune stimulus. They may be produced by 
cells within the brain and spinal cord such as neurons, astrocytes, and oligodendrocytes, 
or by a variety of circulating immune cells (Davies et al., 2006). More recently, cytokines 
have been shown to be associated with exercising skeletal muscle. These cytokines 
termed "myokines" are produced by skeletal muscle and may act to help regulate glucose 
levels during periods of intensive exercise (Pedersen, & Febbraio, 2008). At the present 
time, however, far more research has been conducted on immune related cytokines, and 
the concept of skeletal muscles functioning as an endocrine organ is still a relatively new 
concept.   
2.2.2 The Immune System  
 The immune system is responsible for protecting the body against foreign, 
potentially pathogenic, molecules which would otherwise cause harm through infection 
or disease. Human immunoregulation is a complex process characterized by two branches 
of immunity; the innate and adaptive systems (Medzhitov & Janeway, 1998). Each 
system works synergistically on both systemic and local levels to recognize, attack, and 
destroy foreign materials. Upon initial attack from a foreign molecule the innate system is 
activated. The innate system uses non-specific defenses including physical barriers such 
as the skin and mucous membranes, cells such as phagocytes and natural killer cells, and 
soluble factors such as complement to prevent infection (Janeway & Medzhitov, 2002). If 
the defenses of the innate system fail, the adaptive system is activated and pathogen 
specific defenses are used to fight off infection. A variety of lymphocytes are able to 
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recognize antigens by means of surface receptors and produce specific defensive proteins 
and antibodies to respond (Fabbri et al., 2003).   
2.2.3 Innate Immunity  
 Within the innate immune system, cells known as phagocytes including 
macrophages, dendritic cells, and neutrophils, act on foreign molecules, engulfing and 
destroying them through a process known as phagocytosis (Janeway, & Medzhitov, 
2002). Virally infected cells and cancer cells are dealt with in a different manner through 
a process known as apoptosis in which the cell is stimulated to undergo self-destruction. 
In this process, specialized cells of the innate immune system known as natural killer 
cells prevent viral spreading by releasing pore-forming proteins into the infected cell 
leading to eventual lysis (Biron et al., 1999). Natural killer cells, in addition to 
macrophages, are among the most prolific cytokine producers of the innate immune 
system and through this production, assist in the recruitment of additional immune cells 
during an immune response (Biron et al., 1999). These cytokines may function in 
autocrine or paracrine fashions and can cause a variety of responses including the up-
regulation or down-regulation of the production of other cytokines, an increase in the 
number of a particular surface receptor, or the suppression of their own effects through 
feedback inhibition (Gharaee-Kermani & Phan, 2001).     
2.2.4 Adaptive Immunity  
 Immune cells known as lymphocytes, belonging to the adaptive immune system, 
produce specific responses to invading antigens. The adaptive immune system may be 
categorized into either humoral or cell mediated immunity. Humoral immunity deals with 
extracellular pathogens by means of circulating antibodies. When an antigen is present in 
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circulation, phagocytes such as macrophages, monocytes, and dendritic cells, which 
function as antigen presenting cells (APC’s), are able to initiate an immune response 
(Fabbri et al., 2003). Receptors on the surface of APC’s are activated by molecular 
patterns associated with a pathogen, leading to the increased expression of a protein 
found on the cell surface known as major histocompatibility complex 2 (MHC-2) 
(Cresswell, 1994). This protein is able to accept some of the foreign digested proteins of 
the antigen after it has been destroyed by the phagocyte. It can then present this matter to 
either a naïve T-lymphocytes or a memory T-lymphocyte. Naïve T-cells are a subset of 
T-cells which have never before encountered an antigen. Upon being presented with a 
new antigen a primary immune response is initiated in which the T-cell undergoes 
extensive proliferation within the lymph nodes producing further copies of T-cells 
capable of recognizing the specific antigen (Fabbriet al., 2003). Memory T-cells are those 
which have previously encountered the antigen, and as such, can produce a faster, 
stronger secondary immune response following re-exposure (Dutton et al., 1998). Upon 
being presented with the antigen, T-helper cells, particularly effector cells, are stimulated 
to release cytokines. These cytokines cause the proliferation and differentiation of B-cells 
into memory cells as well as immunoglobulin secreting plasma cells (Litman et al., 
1993). The antibodies produced by these new plasma cells do not directly destroy 
antigens but instead bind to specific antigens and assist in their destruction. Upon binding 
to the antigen, the antibody may act to block the toxic actions of the antigen, or cause the 
clumping of several antigens making them more easily phagocytized (Underdown, & 
Schiff, 1986). In addition, antibodies activate circulating complement which coat 
antigens increasing the likelihood of phagocytization (Underdown, & Schiff, 1986). 
 
 
12 
 
Antibodies are an effective, specialized means of destroying circulating pathogens. 
However, they are unable to enter the cell and act intracellularly (Underdown, & Schiff, 
1986). As such, if the pathogen has already entered a cell, different means of immunity 
are necessary.  
2.2.5 Cell Mediated Immunity  
Cell mediated immunity utilizes activated T-cells in order to attack and destroy 
infected host and foreign cells. T-helper cells bind to the surface of macrophages 
whereby MHC proteins display antigenic determinants (Cresswell, 1994). This binding 
causes the macrophage to release the cytokine interleukin-1 (IL-1) which stimulates the 
proliferation of additional T-cells. The activated T-cells also release additional cytokines 
known as interleukin-2 (IL-2) which cause further proliferation of T-cells including T-
helper cells and T-cytotoxic (Tc) cells (Fabbri et al., 2003). These Tc cells recognize and 
attach to cells expressing the same antigen determinants as the original MHC protein. In a 
process similar to that of natural killer cells, the Tc cell releases perforin into the infected 
cell causing lysis (Fabbri et al., 2003). The remnants of the destroyed cell are then 
engulfed and cleared by phagocytes.     
2.2.6 The Inflammatory Response  
The role cytokines play in cellular communication during both innate and 
adaptive immune responses is an essential component of the body’s defenses. Without 
the increased recruitment and proliferation of necessary immune cells, the body would be 
unable to cope with invading pathogens and tissue damage brought on by infection would 
result. Although healthy individuals are generally able to fight off infection, especially 
 
 
13 
 
when confronted by a pathogen dealt with in the past, at times the body does succumb to 
tissue damage. 
 Whether due to infection or physical trauma, the inflammatory response is 
triggered in order to prevent the spreading of any pathogens, and heal damaged tissue. 
After the onset of trauma, vasodilators such as histamine and bradykinin are released by 
specific leukocytes known as mast cells and basophils. As a result, vessels are triggered 
to vasodilate allowing for an increase in blood flow to the site of the injury (Pober, & 
Cotran, 1990). This hyperemia causes an increase in the rate of delivery of different 
immune cells, as well as the removal of wastes and toxins. In the initial stages of the 
response, clotting proteins such as fibrinogens travel to the injury site and help prevent 
the spreading of pathogens by forming a sticky mesh in the areas adjacent to the tissue 
damage (Ryan & Majno, 1977). Once the pathogens are contained, phagocytic cells such 
as macrophages and neutrophils begin to engulf and destroy any foreign molecules. 
Additional phagocytes are recruited from the circulation by means of a chemical 
attraction to the cytokines released by local neutrophils through a process known as 
chemotaxis (Pober, & Cotran, 1990). As these newly recruited phagocytes travel towards 
the site of inflammation they are seized by the sticky membranes of local endothelial 
cells due to the local production of cell adhesion molecules (Meager, 1999). In addition 
to increased recruitment, enhanced leukocyte proliferation from red bone marrow is 
stimulated by the release of cytokines from activated T-cells through a process known as 
leukopoiesis. Together, this increase in leukocyte proliferation and recruitment aid in the 
inflammatory response and help return the damaged tissue to a healthy state.      
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2.2.7 Cytokine Homeostasis    
 The classification of cytokines is made extremely difficult due to their redundant 
and pleiotropic properties; the latter term referring to the fact that many cytokines exhibit 
multiple effects. They also however, demonstrate redundancy as these effects are often 
the same as those invoked by other cytokines (Sredni-Kenigsbuch, 2002). This causes a 
large degree of overlap, making the categorization of cytokines a daunting task. One such 
method which can be used to distinguish the properties of one cytokine from another is 
by their overall effect on the inflammatory process. In this sense cytokines may be 
deemed as either pro-inflammatory or anti-inflammatory. Pro-inflammatory cytokines act 
to enhance the inflammatory process by promoting leukocyte recruitment and 
proliferation (Hausmann, 2003). In healthy individuals an elevation in pro-inflammatory 
cytokines will be seen during periods of trauma or infection. These cytokines possess the 
ability to pass freely through the blood brain barrier and up-regulate their own expression 
(Hopkins, & Rothwell, 1995). As the damaged tissue is repaired and bacteria and foreign 
matter are engulfed and destroyed, a rise in anti-inflammatory cytokines occurs. These 
anti-inflammatory cytokines act as antagonists and deactivate many of the cytokine-
producing immune cells to help return cytokine concentrations to basil levels (Hausmann, 
2003). This cytokine balance is maintained in healthy individuals but a disruption in 
cytokine homeostasis has been shown to be related to several conditions including SCI.    
2.3.0 Cytokines and Spinal Cord Injury  
2.3.1 SCI and Cytokine concentrations  
 Following SCI, changes in immunoregulation have been shown to coincide with 
chronically elevated levels of circulating cytokines. This elevation is apparent in both the 
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acute and chronic stages of SCI and has been shown whether or not the individual is 
symptomatic for secondary health conditions (Davies et al., 2007). Varying levels and 
severities of SCI between individuals have been shown to have little association with the 
level of systemic cytokines. However, the presence of common secondary health 
complications such as urinary tract infections, neuropathic pain, and pressure sores have 
been shown to be associated with heightened elevations (Hayes et al., 2002). This has 
been shown to be the case with the pro-inflammatory cytokine IL-6 as well as the 
receptor antagonist IL-1RA, as significantly higher systemic levels were found in 
individuals with SCI and to an even further extent if secondary health complications were 
present (Davies et al., 2007). Studies by both Davies et al. (2007), and Hayes et al. 
(2002), also showed elevated levels of the cytokine TNF-α in subjects with SCI. 
However, this finding only reached statistical significance in the study performed by 
Hayes et al. (2002), and secondary health complications were not assessed. When 
examining anti-inflammatory cytokine concentrations, systemic levels of the cytokine IL-
10 were not detected in either of these studies.       
2.3.2 Post-SCI Immune Response  
Whether immune and inflammatory responses are enhanced or suppressed 
following SCI depends on a number of factors including the presence of immune 
enhancing or suppressing cytokines, the receptor levels on glial cells, the activation status 
of cells, and the sequence of exposure to different cytokines (Sredni-Kenigsbuch, 2002). 
Some studies report immunosuppressive effects (Cruse et al., 2000) whereas others show 
chronic inflammation and an up-regulated immune response (Hartung et al., 1991). 
Knowledge regarding this effect is extremely important when considering therapeutic 
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approaches involving immunomodulation. The aim is to promote neuroprotection, tissue 
reconstruction, remyelination, and neural regeneration but if immunosuppression or 
autoimmune responses are to be provoked, certain treatment methods may be detrimental 
(Hayes et al., 2002).  
2.3.3 Immunosuppression  
Communication pathways exist between the nervous and immune system 
whereby lymphoid tissues are innervated by autonomic nerve fibers (Cruse et al., 1992). 
Neuroimmunoregulatory effects are therefore possible whether through a humoral 
response or by direct innervation of lymphoid tissue. The immunosuppression related to 
SCI has been found to be due, at least in part, to a disruption of sympathetic innervation 
of lymphoid organs (Iverson et al., 2000). Autonomic nerve fibers are responsible for 
innervating the lymphoid tissue of several lymphoid organs such as the spleen, thymus, 
and lymph nodes (Cruse, et al. 2000). As these organs are responsible for the production 
of lymphocytes, the nervous system has the ability to directly affect immune system 
functioning. 
 Immunoregulatory function may also be influenced humorally by neurally active 
hormones and neurotransmitters (Carr, 1992). Lymphocytes produced by lymphoid 
organs have several types of hormone and neurotransmitter receptors making them prone 
to neuromodulatory effects (Carr, 1992). Neuroendocrine hormones may be secreted in 
response to the physiological and/or psychological stress associated with SCI and lead to 
a wide variety of immunoregulatory effects, including the immunosuppression of both the 
innate and adaptive immune systems. (Cruse et al., 2000).       
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2.3.4 Immune Up-regulation   
There is also evidence for an up-regulated immune response following SCI due to 
a bias in the immune system towards a particular subset of T-cells. T-cells can be 
categorized into either effector T-cells or regulatory T-cells. Although overall levels stay 
relatively similar, after SCI there is a shift in the predominant T-cell type whereby a 
greater proportion of effector T-cells is evident (Davies et al., 2007). Regulatory T-cells 
are crucial in the maintenance of immunological tolerance and produce 
immunosuppressive effects through the production of anti-inflammatory cytokines 
(Davies et al., 2007). Effector T-cells differentiate into one of two helper T-cell subsets 
including T-1 helper (Th1) cells or T-2 helper (Th2) cells. Th1 cells are responsible for 
the promotion of cell mediated immune responses and predominantly produce pro-
inflammatory cytokines such as, interleukin-2 (IL-2), interferon-gamma (IFN-y), and 
tumour necrosis factor beta (TNF-β). Th2 cells promote humoral immune responses and 
predominantly produce anti-inflammatory cytokines such as, interluekin-4 (IL-4) and 
interluekin-10 (IL-10) (Sredni-Kenisgsbuch, 2002). The shift towards a Th1 cell 
dominance following SCI may lead to a greater proportion of pro-inflammatory 
cytokines. This dominance may be due to several factors including antigen quantity, and 
the initial APC interaction with T-cells (Boonstra et al. 2003). For example, APC’s 
known as dendritic cells will induce the development of Th1 cells when in the presence 
of high antigen levels. As individuals with SCI are prone to secondary health 
complications, the resulting pathogen-derived products may influence the T-helper cell 
response. This shift to a greater proportion of pro-inflammatory cytokines would lead to 
an up-regulated immune response and potentially a state of chronic inflammation.    
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2.3.5 Auto-reactive T-cell Repertoire  
As secondary health complications will be associated with infection and high 
antigen levels, a cytokine imbalance caused by a shift to Th1 cell dominance would be 
expected. However, this imbalance has been shown even when no signs of secondary 
health complications are present. It has been proposed that this is due to a phenomenon 
known as the trauma induced autoreactive T-cell repertoire. The tissue damage brought 
on by spinal trauma is likely to release a variety of CNS proteins capable of inducing an 
autoimmune reaction. Over time, T-cells may begin to respond differently to certain 
proteins not originally associated as an antigen, leading to an immune response directed 
at host tissue (Popovich et al., 1996).  
2.3.6 Immune System Homeostasis  
An increase in pro-inflammatory cytokine production would have seemingly 
beneficial effects concerning neuronal survival and tissue repair after SCI but the 
disruption in immune system homeostasis has the potential to lead to immune 
dysfunction and immunopathogenesis. In addition, evidence exists showing that 
chronically elevated cytokine concentrations may contribute to axonal dysfunction 
(Davies et al., 2006). Therefore, it would seem that the maintenance of normal cytokine 
concentrations is a determining factor as to whether they will function in a positive 
physiologic and neuromodulatory manner, or lead to immune and axonal dysfunction as 
seen in a variety of neuropathies.  
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2.4.0 Neuropathy  
2.4.1 Peripheral Nerves   
 Peripheral nerves consist of bundles of axons which exit and enter the central 
nervous system from various sites along the spinal cord and brain stem. They are 
categorized by the direction in which they carry signals and the function which is carried 
out by those signals. Afferent, or sensory fibers, receive signals from dermatomes and 
myotomes and carry them to the CNS, whereas, efferent, or motor fibers, conduct signals 
from the CNS to the target tissue. An individual axon can reach lengths of up to one 
meter, and as such, the ability to transmit signals rapidly while maintaining signal 
strength is of extreme importance. Supporting cells of the peripheral nervous system 
known as Schwann cells ensure the structural integrity of the neuron is maintained, and 
thereby act to sustain signal strength. By growing around the axon and producing several 
layers of lipid based protective covering known as myelin, Schwann cells act to insulate 
the axon. As lipids are poor conductors of electrical current, this covering provides a 
strong insulator to help contain travelling signals.   
2.4.2 Signal Transmission  
The axon is segmented into regions of myelinated and non-myelinated areas. 
Although myelinated areas are extremely important concerning efficient signal 
transmission, non-myelinated areas are necessary for the re-initiation of action potentials. 
Signals are typically generated at a region where the axon joins the cell body known as 
the axon hillock. As the signal travels along the axon it is re-initiated at non-myelinated 
regions known as Nodes of Ranvier. These regions are densely populated with voltage 
regulated gates which allow the signal to be boosted back to its original strength. This 
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process occurs at an extremely rapid rate and is termed saltatory conduction due to the 
way the signal seemingly jumps from one node to the next (Huxley, & Stampfli, 1949).       
 At the site of the axon hillock and each Node of Ranvier, the exchange of sodium 
and potassium ions causes an alteration in the resting membrane potential. As the action 
potential generated from the previous node travels to the next, the membrane becomes 
depolarized, stimulating the opening of a number of sodium channels. This allows an 
influx of sodium (Na
+
) to diffuse into the cell, leading to further depolarization and 
stimulating the opening of additional Na
+ 
channels. If this depolarization meets the 
threshold of approximately -55mv, the triggering of a new action potential will result. 
Upon reaching threshold, Na
+ 
channels close, preventing further depolarization, and 
potassium (K
+
)
 
channels open, allowing an efflux of K
+
 ions to diffuse out of the cell, 
causing repolarization and the return of resting membrane potential (Shrager, 1988). 
These action potentials are non-graded, meaning that regardless of the strength of the 
stimulus applied, as long as the threshold is met, a standardized amplitude action 
potential will always be produced. These action potentials are also non-decremental 
meaning they maintain their strength as they travel along the axon. This is due to the 
constant re-initiating of the action potential at each Node of Ranvier. As the action 
potential arrives at the next node in the sequence the signal will be just strong enough to 
cause opening of the voltage gated channels and initiate a new action potential of equal 
strength to that of the previous node. Electrical signaling such as this is an effective 
communicatory pathway but can be performed only along a single continuous axon. 
Therefore, when an impulse must transition between two neurons, or from a neuron to a 
muscle fiber, such as that seen at the site of the neuromuscular junction, a different means 
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of signaling must be utilized. This is accomplished through chemical signaling by means 
of neurotransmitter release (Dulhunty, 2006).  
Upon reaching the targeted skeletal muscle, the electrical impulse traveling along 
the pre-synaptic neuron must be converted to a chemical signal, cross the synaptic cleft, 
and initiate a new electrical impulse on the post-synaptic muscle fiber. This is 
accomplished through the release of the neurotransmitter acetylcholine (ACh) from 
vesicles within the pre-synaptic neuron. Upon being released, ACh crosses the synaptic 
cleft whereby it binds to receptors which open chemically gated channels (Dulhunty, 
2006). This allows Na
+
 ions to flow into the muscle fiber causing depolarization of the 
resting membrane potential and the production of a new action potential.  
The newly generated impulse then travels along specialized tubes known as 
transverse tubules (T-tubules) which carry the signal deep into the muscle fiber. These T-
tubules transport the impulse to an internal membrane system responsible for housing 
calcium (Ca
++
) ions known as the sarcoplasmic reticulum (SR). Upon stimulation of the 
SR, Ca
++
 ions are released into the cell (Gordon et al., 2000). This release is a crucial 
component in the contraction of skeletal muscle, and is required for the functioning of 
specialized contractile proteins. Contractile proteins including a thick filament composed 
of myosin and a thin filament composed of actin cause the contraction of skeletal muscle 
through the formation of crossbridges. Molecules of actin have binding sites for myosin 
which, through an energy dependent process, allow for contraction by means of a process 
known as the sliding filament theory. However, until stimulated by the release of Ca
++
 
ions, these binding sites remain blocked by a protein known as tropomyosin. The binding 
of Ca
++
 ions to an associated protein known as troponin causes a conformational change 
 
 
22 
 
in tropomyosin, revealing the actin binding sites and allowing for crossbridge formation 
(Gordon et al., 2000). The myosin heads may then perform a power stroke causing a 
shortening in sarcomere length, and ultimately a skeletal muscle contraction.  
The above describes neuronal functioning and signal transmission under normal 
healthy conditions. With the support from glial cells, neurons function to send and 
receive both motor and sensory signals throughout all regions of the body. This system is 
however, extremely sensitive to any disturbances whether due to physical trauma or 
disease, and as such, is susceptible to a variety of neuropathies.   
2.4.3 Channelopathy  
 Conduction deficits may also occur despite a lack of any structural degradation or 
demylination. This has been shown in studies examining remission periods of individuals 
suffering from multiple sclerosis. These remission phases are characterized by periods of 
rapid recovery which occur too quickly to possibly be attributed to re-myelination 
(Papakostopoulos et al., 1989). Evidence exists that these non-structural based 
conduction deficits are caused by disorders of ion channels known as channelopathies. It 
has been suggested that molecules such as cytokines, antibodies, and toxins may interfere 
with sodium (Na
+
) and potassium (K
+
) channels causing increased or decreased nerve 
excitability (Gutmann, & Gutmann, 1996). If a Na
+
 channel is to become blocked, the 
intracellular flow of Na
+
 ions is reduced, making depolarization more difficult or 
potentially even causing complete conduction block. This will result in a reduction in 
action potential propagation velocity, as well as compound action potential amplitude 
(Gutmann, & Gutmann, 1996). The blockage of K
+
 channels will result in difficulty 
repolarizing the cell. A K
+
 channel block will cause a decrease in the extracellular flow of 
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K
+ 
leading to high frequency, repetitive action potentials (Gutmann, & Gutmann, 1996). 
Similar effects concerning difficulty repolarizing the cell will occur if the opening of Na
+ 
channels is to be prolonged. This may occur due to an immune interference leading to the 
prevention of channel inactivation. As a result, the neuron may become hyperexcitable 
leading, once again, to high frequency, repetitive action potential firing. It has been 
suggested that this immune interference is brought on by the demyelination experienced 
after nerve trauma. It is possible that the demyelination reveals epitopes which cause an 
antibody response against Na
+
 channels, causing a decline in the rate of inactivation 
(Landon, & Langley, 1971). Support for other immune constituents effecting signal 
conduction, such as cytokines, has also been produced.  
 The cytokine tumour necrosis factor alpha (TNF-α) has been shown to have both 
pro and anti-inflammatory effects as well as neuroprotective, neurotoxic, and neuroplastic 
properties (Davies et al., 2006). At normal physiological levels TNF-α has been shown to 
enhance synaptic transmissions through the modification of ion channel kinetics, 
however, at chronically elevated levels it may be cytotoxic leading to axonopathy, 
oligodendrogliopathy, or channelopathy (Davies et al., 2006). Tumour necrosis factor 
alpha may increase the intracellular flow of Na
+
 into the cell as well as the extracellular 
flow of K
+
 out of the cell causing enough depolarization to induce conduction failure. 
This accumulation of Na
+
 is also linked to increased calcium (Ca
++
) import which causes 
further disruption through the production of reactive oxygen species (Davies et al., 2006). 
A study by Davies et al. (2006), showed the effects of TNF-α on electrophysiological 
properties of an excised guinea pig spinal cord. It was shown that exposure to the 
cytokine caused a dose dependent and reversible depolarization of membrane potential 
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and a reduction in compound action potential amplitude. These effects were observed 
under TNF-α concentrations as low as 10ng/ml and were increasingly amplified when 
under higher concentrations (100, 1000, 5000ng/ml). Further evidence that it was in fact 
the cytokine producing the response and not the presence of other proteins was provided 
when exposure to heat denatured TNF-α caused no response. This study provided 
compelling evidence that elevations in systemic cytokine concentrations can in fact 
induce channelopathic effects in vitro. These same effects however, have yet to be proven 
in vivo, in humans.  
2.4.4 Macrophage Mediated Cytotoxicity  
 Non-specific tissue destruction may also occur due to macrophage mediated 
cytotoxicity. The release of cytotoxic cytokines and free radicals may lead to 
demyelination despite the fact that neither the axon nor Schwann cells are specifically 
targeted (Kiefer, et al., 2001). A strong inflammatory response is capable of causing such 
mediators to leak into untargeted surrounding tissue leading to further damage. Although 
this form of cytokine induced conduction deficit is structurally based, and therefore not 
the focus of the current study, the observation that cytokines may affect signal 
transmission in multiple forms is worth acknowledgement.   
2.4.5 Neuropathy and Spinal Cord Injury  
 The fact that myelinopathies and channelopathies can affect healthy, intact 
neurons has major implications when concerning individuals with SCI. As some of the 
neural tracts may be spared from the original trauma-inducing injury they have the 
potential to continue partially innervating tissue and relaying sensory information. 
However, these neuropathies may reduce or eliminate the signal production and 
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transmission capabilities of healthy neurons. Whether due to demyelination, alterations in 
ion channel kinetics, or a combination of the two, motor and sensory capabilities would 
become greatly reduced. As such, the true motor and sensory potential of individuals with 
spinal cord injury may not be met. New methods of reducing neuropathy inducing 
immune constituents could therefore prove invaluable to this population. A potential 
relationship between immune constituents and nerve function in humans was shown in a 
study by Mcdonald et al. in 2002. A single subject with an ASIA A, C2 level spinal cord 
injury was examined over a 3 year period. The individual, who was 5 years post injury, 
had shown no improvement in motor or sensory capabilities in the years leading up to the 
study. An activity based recovery program was implemented in which the participant 
partook in a thrice weekly, one hour bout of functional electrical stimulation cycling. 
Over a three year period the subject improved from the original ASIA A classification to 
an ASIA C classification. Interestingly, the subject’s neurological recovery increased in 
parallel with a decline in infection rates. These findings alone may not provide strong 
enough evidence to attribute a reduction in immune constituents as the sole contributor to 
neurologic recovery, but do however create an intriguing possible mechanism worthy of 
further examination.   
2.5.0 The Cytokine Response to Exercise  
2.5.1 Exercise and Elevations in Cytokine concentrations     
Up until the early 1990’s cytokines were viewed solely as molecules involved in 
the regulation of immune responses. They were typically believed to be secreted by, and 
act on, a variety of immune cells in both paracrine and autocrine fashions. They have 
since been found to be secreted by non-immune cells and play a role extending far 
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beyond mere immunoregulation. Several cytokines, termed myokines, have been found to 
be secreted by contracting skeletal myocytes and produce both immunoregulatory and 
energy regulating effects.    
 Exercise induced-elevations in cytokines have been shown after periods of 
prolonged, strenuous physical activity. These increases are most pronounced in the pro-
inflammatory cytokine interleukin-6 (IL-6), however, increases in other pro-
inflammatory cytokines in addition to anti-inflammatory cytokines are also apparent 
(Nortoff & Berg, 1991). A study by Ostrowski et al. (1999), examined plasma pro-
inflammatory and anti-inflammatory cytokines, as well as cytokine inhibitors in male 
subjects following a 3.5 hour marathon race. The pro-inflammatory cytokines IL-6 and 
TNF-alpha, as well as the anti-inflammatory cytokine IL-10 were all found to peak 
immediately following the cessation of exercise and increased by 128, 2.3, and 27 fold, 
respectively. The cytokine inhibitor IL-1RA was found to peak 1 hour after the cessation 
of exercise and was elevated by 39 times its resting value (Ostrowski et al., 1999). The 
fact that a cytokine spike may be induced by means of aerobic exercise provides the 
opportunity for the examination of their acute affects in a laboratory setting. Although the 
examination of the acute effect of cytokines following actual infection may be more 
ideal, predicting when and in whom an infection will occur makes it somewhat 
impractical in a laboratory setting. However, it has been shown that exercise-induced 
cytokine spikes can reach levels similar to those seen during periods of inflammation 
(Pedersen & Febbraio, 2008). For example, a study by Ullum et al. (1994), showed a 2 
fold increase in IL-6 following 1 hour of cycling corresponding to 75% VO2 max. This 
elevation closely mimics those typically seen following SCI (Hayes et al., 2002).      
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2.5.2 Skeletal Muscle Damage and Cytokines  
As activated monocytes are one of the primary sources of IL-6 during an 
inflammatory response, it was originally assumed that monocytes would be responsible 
for the production of IL-6 during exercise as well. The increase in plasma IL-6 found 
during exercise is however not matched by a change in IL-6 mRNA levels in 
mononuclear cells (Ullum et al., 1994). The same was shown to be true for the production 
of the cytokines TNF-α and IL-1β (Starkie et al., 2001). As mRNA is a precursor for, and 
necessary in, the production of these cytokines, it would seem that monocytes are not the 
source of elevated cytokine concentrations seen during exercise.    
The possibility of contracting skeletal muscle as a source of exercise-induced 
cytokines gained attention after IL-6 mRNA was found to be increased within skeletal 
muscle following a period of strenuous exercise (Ostrowski et al., 1998). This increase 
was believed to be stimulated due to the inflammatory response brought on by the 
damaging of myofibres during exercise. This explanation seemed fitting due to the 
known increases in cytokine concentrations during immune-mediated inflammatory 
responses. However, a major flaw in this theory was discovered when similar elevations 
of cytokines were found to result when using cycling as a mode of exercise. As cycling 
results in only very minor levels of muscle damage it does not generally invoke an 
inflammatory response (Starkie et al., 2001). As such, it would seem that the 
inflammatory response could not possibly be the main stimulating factor associated with 
the exercise-inducedelevation in cytokines. Further evidence for this theory was provided 
in a study by Croisier et al. (1998), in which subjects performed two bouts of eccentric 
exercise separated by a three week period. As each of the training bouts were identical, it 
would be expected that training adaptations would result in a much lower level of muscle 
 
 
28 
 
damage following the second bout, as could be shown through serum levels of 
myoglobin. However, despite the fact that the second exercise bout resulted in 
significantly lower levels of muscle damage, serum IL-6 levels were very similar 
(Croisier et al., 1999). Therefore, although muscle damage and the resulting 
inflammatory response may play a small role in cytokine elevations during and after an 
exercise bout, it does not appear to be the primary cause.  
2.5.3 Contracting Skeletal Muscle and Cytokines  
 Despite providing some evidence suggesting the role of contracting skeletal 
muscle in the production of cytokines, the aforementioned studies offer no conclusive 
evidence. It is possible that the elevations in cytokines are due to other factors such as 
hormones, and metabolites produced during exercise which may mediate cytokine 
production. In order to irrefutably show that the contraction of skeletal muscle causes 
increased cytokine release, a study by Steensberg et al. (2000), examined the levels of 
cytokines and potential mediators in the exercised vs. unexercised leg. Using 
catheterization in the femoral artery and vein of the exercised and rested leg, the levels of 
IL-6 and its potential mediators were measured. It was shown that both legs had 
equivalent cytokine mediator levels, but that only the exercised leg released IL-6 
(Steensberg et al., 2000). This provides evidence suggesting that it may be contracting 
skeletal muscle per se which leads to an increase in local and systemic cytokine 
concentrations during exercise. The main shortcoming of the technique used, is that using 
anterio-venous difference shows only the change in cytokine concentrations across a 
tissue region. The change in cytokines could therefore be the result of several possible 
sources including, local immune cells, adipose tissue, skeletal muscle, or bone 
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(Steensberg et al., 2000). Therefore, skeletal muscle cannot definitively be deemed a 
source of cytokines based on these results.     
 It was not until 2004 that strong evidence as to the cellular source of cytokines 
was obtained. Through the use of immunohistochemistry, in which an antibody to IL-6 
was fluorescently labeled, visual observation of the amount of IL-6 and mRNA within 
individual myofibres was made possible. It was shown that following two hours of 
cycling, an increase in both IL-6 and mRNA was evident within individual myofibres in 
comparison to resting state (Hiscock et al., 2004). This study provided convincing 
evidence that contracting skeletal myocytes are in fact a source of IL-6 during exercise.        
2.5.4 IL-6 and Energy Regulation  
Inducing elevations in IL-6 is possible in-vitro by means of cell culture, or in-vivo 
by means of exercise. By taking individual myocytes and passively stretching them, it is 
possible to induce a secretion of IL-6 (Peterson & Pizza, 2009). When examining IL-6 
kinetics during exercise, a general trend is seen concerning the rate of its release over the 
span of long duration exercise sessions. Steensberg et al. (2001), showed that over a five 
hour exercise period IL-6 levels remained moderately elevated for the initial three hours, 
but increased at a much higher rate over the remaining 2 hours. This observed change in 
myokine kinetics is interesting as it appears to coincide with decreasing muscle glycogen 
levels. If myokine release is elevated as muscle glycogen stores are depleted, it may point 
to an important myokine-mediated response to an energy crises. This idea gained further 
support after it was shown that consuming exogenous carbohydrates during an exercise 
bout actually reduced the systemic level of IL-6 (Nehlsen-Cannarella et al., 1997). Upon 
depleting muscle glycogen stores, contracting skeletal muscle must rely on blood glucose 
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and other substrates as energy sources. The fact that IL-6 levels seem to be inversely 
correlated with muscle glycogen levels would suggest that it plays a key role in fuel 
regulation and maintenance of blood glucose levels during exercise.  
If this regulation is to occur, it would be accomplished through stimulation of the 
liver to increase glucose output. Increased hepatic glucose output is necessary during 
times of muscle glycogen depletion as the muscle will begin to utilize blood glucose for 
energy, thereby lowering blood sugar levels. Therefore, in order to maintain appropriate 
blood glucose levels, an increased release of glucose from the liver is necessary. The 
ability of IL-6 to stimulate hepatic glucose production was examined in a study by 
Febbraio et al., (2004), in which subjects received IL-6 infusion during exercise. It was 
shown that subjects receiving IL-6 had much higher endogenous glucose production than 
those working at similar intensities without IL-6 infusion. As other regulators of hepatic 
glucose production such as insulin, glucagon, and cortisol, did not differ between groups, 
it would appear that IL-6 contributes to the stimulation of hepatic glucose output.  
2.6.0 Measurement of Peripheral Nerve Function 
2.6.1 Electromyography and Electrode Type  
Electromyography (EMG) is used to convert the electric potential generated by 
muscle to a visual signal which can be displayed and analyzed for the purposes of 
examining neuromuscular function and diagnosing potential neuromuscular disorders. By 
creating a visual representation by means of an oscilloscope, several physiological 
properties can be examined. Upon determining the time taken for an impulse to travel a 
given distance and cause a motor response, the speed of action potential propagation or 
nerve conduction velocity through the peripheral nerve can be established. It is also 
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possible to find the strength of the motor response through assessment of specific wave 
forms. Obtaining accurate measurements of electrophysiological signals can often prove 
quite difficult, due to numerous sources of noise, and several internal and external factors 
which can influence conduction. As such, proper and consistent use of instrumentation 
becomes crucially important in order to limit error and obtain accurate measures of 
electromyographical signals.  
Electrode type is one such factor requiring careful consideration when performing 
an electromyographic assessment. Electrodes placed either on the skin, known as surface 
electrodes, or inserted directly into the muscle, known as indwelling electrodes, are used 
to collect muscle generated ionic potentials and convert them to electronic potentials 
through a process known as signal transduction (Drost et al., 2006). Each type has its own 
unique advantages and disadvantages in regards to the specificity of the signal obtained 
and the associated noise. Surface electrodes termed “floating electrodes” are placed over 
the skin on top of a thin layer of electrolyte gel. They are advantageous in the sense that 
they provide a non-invasive, relatively simple method of obtaining signals, but also have 
several shortcomings. The fact that the electrodes are placed over a layer of gel makes 
them susceptible to a form of noise known as motion artifact due to changes in gel 
thickness (Talhouet & Webster, 1996). In addition, although receiving signals from some 
distance away from the muscle allows for the obtainment of information about the “big 
picture”, obtaining highly specified signals is not possible. This distance also makes them 
susceptible to a phenomenon known as crosstalk in which signals from muscles unrelated 
to those of interest, pollute the desired signal. As such, obtaining clear signals from 
deeper and/or smaller muscles becomes quite difficult (Bogey et al., 2000). When highly 
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specified signals are desired, indwelling electrodes may be more appropriate. Although 
more invasive, indwelling electrodes have the ability to detect individual motor unit 
action potentials and can be placed directly into the muscle allowing for signal recordings 
of deeper muscle groups (Bogey et al., 2000). Whether a surface or indwelling electrode 
is more appropriate for a given test will therefore depend on the location of the muscle 
group in question, as well as the desired specificity of the signal.      
2.6.2 Electrode Configuration  
Both the configuration and placement of electrodes are crucial aspects of accurate 
recordings. Electrodes are most commonly placed in one of either a monopolar or bipolar 
configuration. A monopolar configuration uses one electrode to record muscle activity 
while a second and third act as the reference and ground. In a bipolar configuration two 
recording electrodes are placed over the muscle. The placement of two recording 
electrodes over the muscle makes a bipolar configuration more effective concerning noise 
reduction. As the signal will be obtained twice, the subtraction of one signal from the 
other makes it possible to eliminate much of the unwanted noise while maintaining the 
true signal. However, when determining nerve conduction velocity (NCV) a monopolar 
configuration is more appropriate. As the determination of NCV is based on the time 
period between initial stimulation of the nerve and the invoked motor response, the use of 
two electrodes will result in a less accurate measurement. This is due to the fact that the 
time taken for the impulse to travel from the first to second electrode will affect the 
calculated latency period, resulting in a slower calculated NCV. As such, the use of a 
monopolar configuration will result in more accurate results as the latency period will be 
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based only on the time taken for the impulse to travel from the point of stimulation to the 
motor point of the muscle. 
Proper and consistent placement of electrodes as well as point of stimulation is 
also very important when concerning the obtainment of precise measures. In order to 
achieve the most accurate signal, the recording electrode must be placed directly over the 
motor point. The motor point is a region in which the lowest level of electrical 
stimulation will result in a muscle twitch (Roy, et al., 1986). As such, by stimulating 
different areas of the muscle with a very low voltage, the motor point can be located. As 
a monopolar configuration uses only one recording electrode, proper inter-electrode 
distance does not apply. However, it is necessary to keep the distance between the point 
of stimulation and the recording electrode consistent between testing. Any changes in this 
distance will result in variations in the calculated nerve conduction velocity which may 
be falsely attributed to fiber characteristics.   
2.6.3 Signal Amplification and Filtering  
Upon being converted through signal transduction, the small electronic potentials 
travel to an amplifier whereby the magnitude is increased to a level large enough to be 
recorded and analyzed. The amplifier also acts as a filter, removing unwanted noise 
through a process known as differential gain. As the electrodes are placed at some 
distance apart, the action potential will not be detected at exactly the same time. 
Therefore, any signal that is detected at exactly the same time is considered noise known 
as “common mode” and can be eliminated. The complete elimination of noise is not 
possible due to the fact that common mode signals will never be completely identical due 
to differing electrode-skin impedances. Amplifiers have however been shown to be quite 
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effective at removing noise which can be shown through a measure of effectiveness 
known as the common mode rejection ratio. Additionally, amplifiers possess the ability to 
filter out signals of specific frequencies. High frequency filters act to block any low 
frequency signals allowing only high frequency signals through, while low pass filters act 
in an opposite fashion. Band pass filters can also be used in which both high and low 
frequency signals can be excluded, leaving only those signals in the middle frequency 
range. Each of these filters can be used to eliminate unwanted signals while maintaining 
signals within a particular range of interest.   
2.6.4 Electromyographic Waveforms  
Upon being filtered and amplified, the analog EMG signal is either displayed 
directly onto an oscilloscope or converted into a digital waveform by means of an analog-
to-digital conversion board. As an oscilloscope displays latency periods and wave 
amplitudes, it is sufficient when determining nerve conduction velocity, and the strength 
of the motor response. An invoked potential will produce a standardized set of 
waveforms which can be interpreted to provide information about a number of 
electrophysiological responses. When invoking a potential, the stimulator is oriented such 
that the cathode faces the intended target. Therefore, if the invoking of a direct motor 
response is desired, the cathode will face the targeted muscle group. Immediately 
following initial stimulation the oscilloscope displays a short duration spike known as the 
shock artifact. The waveform is followed by a period of relative electrical silence until 
the occurrence of a wave of larger amplitude and longer duration. This wave is known as 
the M-wave and represents the motor response of the muscle. The time between the 
shock artifact and the M-wave therefore represents the amount of time taken for the 
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impulse to travel along the peripheral nerve before reaching the muscle. This time phase 
is termed the latency period and can be used in the calculation of NCV. Simply by using 
this information in conjunction with the distance the impulse traveled, the NCV can be 
calculated. The amplitude of the M-wave also provides important information about the 
strength of the motor response. It is positively related to the strength of the applied 
stimulus and can provide information about motor unit recruitment. For example, the 
lowest possible stimulus which will invoke a twitch represents one motor unit, whereas a 
supramaximal stimulus represents the recruitment of all motor units. This may be used as 
a methodological control, making certain that the same numbers of motor units are 
always recruited and ensuring that any changes seen are due to actual physiological 
responses and not simply due to methodological errors.    
The strength of the applied stimulus will also affect which type of nerve is 
stimulated and the resulting waveforms produced. As motor neurons are much smaller in 
diameter than sensory neurons they produce a greater resistance to travelling signals. 
Therefore, a larger stimulus is required in order to directly stimulate alpha motor neurons 
than that required to stimulate 1a sensory neurons. As such, if the stimulation is not 
strong enough, only sensory fibers will be stimulated and the amplitude of the M-wave 
may be significantly reduced or abolished. In this case, a delayed waveform known as the 
H-reflex occurs. This delay occurs due to the fact that sensory fibers carry the signal back 
to the spinal cord before relaying the message to the muscle through motor fibers. As 
stimulation is increased, alpha motor neurons will eventually be stimulated resulting in an 
M-wave. If this stimulation continues to be increased, antidromically propagating signals 
of the M-wave will begin to travel away from the muscle, back towards the spinal cord 
 
 
36 
 
causing a collision with the orthodromically propagating signals of the H-reflex. As the 
M-wave amplitude increases, the amplitude of the H-reflex will begin to proportionally 
decline until it is completely abolished. Although the H-reflex is not the waveform of 
interest when examining nerve conduction velocity, the ability to differentiate between it 
and the M-wave is critically important concerning accurate measurement.  
2.7.0 Summary  
 As cytokines have been shown to be at elevated levels following SCI it is 
important to determine whether the channelopathic affects seen in animal models also 
occurs in humans. The discovery of skeletal muscle as an endocrine organ allows for the 
manipulation of systemic cytokine concentrations, providing the unique opportunity to 
examine such effects in humans in vivo. The elevations in myokines observed following 
periods of strenuous exercise have been shown to be comparable to levels during periods 
of inflammation, making it an appropriate method of examining the acute effects on 
peripheral nerve function. Should cytokines be shown to negatively influence nerve 
function, the implications regarding individuals with spared neural tracts could prove 
invaluable. Future studies may begin to examine methods of reducing systemic cytokine 
concentrations, or preventing ion channel disruption. This would allow spared neural 
tracts to begin affectively participating in signal transmission thereby returning partial 
motor and/or sensory function. 
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III. Purpose and Hypothesis  
 
3.1.0 Statement of Purpose 
 
The purpose of this study is to determine the acute effects of exercise-induced 
elevations in cytokines on human peripheral nerve function in vivo.   
 
3.2.0 Hypothesis    
 
It was hypothesized that an elevation in systemic cytokine concentrations would 
lead to conduction deficits due to the proposed channelopathic effects of cytokines. 
Specifically, one hour of intense aerobic exercise was expected to increase each of the 
cytokines of interest to at least two-fold its original resting values. In terms of peripheral 
nerve function, it was expected that post nerve conduction velocity tests would show a 
decline in the speed of action potential propagation in comparison to pre-intervention 
values. Conduction deficits were also expected to lead to decreased post-intervention 
values in both muscular strength and endurance. Lastly, the time taken to perform a 
finger dexterity test was expected to increase. Overall, upon completion of the exercise 
intervention, an elevation in systemic cytokine concentrations is expected to have 
detrimental effects concerning peripheral nerve function, and as such, produce negative 
affects concerning each of the functional measures.           
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IV. Methodology  
4.1.0 Subjects  
 Twelve healthy, able-bodied, college-aged males from Brock University were 
recruited for participation in this study. Participants were all between the ages of 20-24 
and had an average age of 23.3 years. Participant weights varied from 67.9-96.5kg with 
an average weight of 80.9kg. All participants were recreationally active, but did not 
participate in competitive sports at an elite or varsity level. All participants were healthy, 
with no signs of neuromuscular disease or contraindications to vigorous physical activity, 
as ensured through the completion of a PAR-Q form prior to participation. Any signs of 
these conditions would have resulted in the exclusion of the individual from the study. 
Upon completion of the PAR-Q form informed consent was obtained from all subjects. 
All subjects were informed of their right to decline participation in the study or withdraw 
at any time without penalty.   
4.2.0 Exercise Intervention Protocol  
 The exercise intervention consisted of 2 bouts of cycling for a duration of 1 hour 
per session. The chosen mode and duration of the intervention was deemed the most 
appropriate method of inducing a cytokine spike as exercise involving large muscle 
groups, and occurring over longer durations has been shown to lead to the largest 
increase in systemic cytokines (Pederson & Febraio, 2008). The first bout was performed 
on Day 1 during the familiarization period in order to determine the appropriate relative 
intensity each subject would be working at on Day 2, as well as to determine fluid loss. 
By calculating each subjects target heart rate it was possible to set an intensity that would 
ensure all subjects were working at a high yet sustainable rate. All subjects performed the 
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cycle at an intensity corresponding to approximately 65% VO2max. This intensity was 
monitored during exercise through the use of heart rate reserve (HRR), as it has been 
shown to be highly correlated (r = 0.990) with %VO2max (Swain et al. 1998). By 
determining each subject’s maximum heart rate and resting heart rate it was possible to 
determine HRR and target heart. Each subject was then told their target heart rate 
corresponding to 65% HRR. Percentage HRR has been shown to be an accurate predictor 
of intensity and ensured all participants cycled at the same relative, high yet sustainable 
intensity.  At the midpoint (30 min) of the initial exercise bout, the wattage and RPM 
each subject was working at in order to maintain their target heart rate was recorded. This 
wattage and RPM was to be used as a measure of intensity for the exercise intervention 
on Day 2. The use of wattage and RPM as opposed to heart rate during the exercise 
intervention allowed for a more consistent means of monitoring intensity as cardiac drift 
was not a confounding factor. As hydration levels can greatly affect measures of nerve 
function, fluid loss over the initial bout of exercise was determined. Each subject was 
weighed prior to and following the exercise bout and fluid loss was estimated based on 
weight loss (see table #1). The estimated fluid loss was then used as a means of 
determining necessary fluid intake to be consumed during the exercise intervention on 
Day 2. The exercise intervention on Day 2 was performed a minimum of 72 hours after 
the familiarization session to provide an adequate time period for any elevations in 
cytokine concentrations to return to basal values prior to measuring resting cytokine 
concentrations as seen during baseline testing. During the exercise bout subjects 
consumed water at 6 time points (every 10 minutes) over the span of the 1 hour exercise 
intervention in order to ensure hydration levels were maintained. As nerve conduction 
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velocity has been shown to be effected, not only by cytokines, but by exercise related 
factors such as metabolites, temperature, and hydration levels, a method of controlling for 
these factors was necessary. Local metabolite production and temperature change were 
controlled for by assessing all outcome measures in the inactive left arm as opposed to 
taking measures at a location near the active muscles of the legs. Lastly, as all measures 
were taken 30 minutes after the cessation of exercise, enough time was provided for any 
elevations in temperature to return to normal. The return to temperatures close to that of 
pre-exercise levels was insured by monitoring skin temperature by means of a surface 
temperature thermometer utilized prior to all pre and post-exercise measures (see table 
#1). Each exercise session began with a 5 minute warm up period and ended in a 5 
minute cool-down period in which the subject was instructed to cycle at a light intensity 
of their choosing. All subjects were required to maintain the set intensity and complete 
the 1 hour cycle in its entirety, or their results were to be excluded from the study. 
Table #1: Subject Temperature and Weight prior to and following exercise bout 
Subject Pre-exercise 
Temp (ᵒ C) 
Temp1h 
Post (ᵒ C) 
Temp 2h 
Post 
(ᵒ C) 
Temp 
2h Post 
(ᵒ C) 
Pre-
Exercise 
Weight (kg) 
Post 
Exercise 
Weight (kg) 
1 30.4 28.5 28.2 31 94.94 94.1 
2 33.0 33.6 32.8 33.1 81.7 80.9 
3 32.6 31.6 30.0 32.8 81.8 81.0 
4 33.8 33.1 31.9 32.7 86.9 86.0 
5 29.6 32.2 32.9 25.6 67.9 67.2 
6 31.2 31.5 33.3 29.7 69.2 68.4 
7 31.7 30.8 32.0 29.1 70.5 69.8 
8 30.8 31.1 31.3 29.9 75.8 75.1 
9 30.8 31.6 33.8 33.1 77.3 76.7 
10 33.3 31.7 34.7 34.6 96.5 95.3 
11 30.5 31.2 31.5 32.4 88.4 87.8 
12 32.2 34.0 34.1 31.3 80.1 78.4 
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4.3.0 Outcome Measures  
 All outcome measures were taken both before and after the exercise intervention 
to determine any changes in each of the testing variables under basal cytokine 
concentrations in comparison to elevated cytokine concentrations. The first assessment of 
nerve conduction velocity (NCV) was performed on Day 1 during the familiarization 
session. On Day 2, baseline testing was performed prior to the exercise intervention and 
included an assessment of NCV, functional measures, and cytokine concentrations. Blood 
draws were taken for the analysis of cytokine concentrations, followed immediately by 
NCV testing and the remaining functional measures. The first blood draw was taken 30 
minutes after the cessation of exercise in order to allow adequate time for each of the 
cytokines of interest to reach elevated levels (Ostrowski et al., 1999). Post testing of each 
measure, with the exception of cytokine concentrations, was also repeated at 1 hour, 2 
hours, and 24 hours post-exercise in the same fashion as baseline testing. Measures at 
multiple time points were necessary due to the potential delay of channelopathic effects.    
4.3.1 Cytokine Concentrations  
 Cytokine concentrations were determined through the obtainment of blood draws 
from the antecubital vein of each subject. A total of 10ml of blood was taken at both the 
pre and post testing periods. The cytokines of interest included interleukin-6 (IL-6), 
interleukin-10 (IL-10), tumour necrosis factor-α (TNF-α), and interleukin-1 receptor 
antagonist (IL-1RA). As different cytokines reach peak levels at unique times following 
exercise, it was necessary to perform post-exercise blood draws at an appropriate time to 
ensure each cytokine of interest was adequately elevated. The cytokines IL-6, IL-10, and 
TNF-α have all been shown to peak immediately following the cessation of exercise, 
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whereas the receptor antagonist IL-1RA has been shown to peak 1 hour after the 
cessation of exercise (Ostrowski et al., 1999). As both IL-6 and IL-10 levels begin to 
decline rapidly immediately after peaking, it was necessary to obtain the blood draws at 
30 minutes following the cessation of exercise. Upon obtaining the blood draws, the 
blood was allowed to clot for 20 minutes. The serum was separated from the whole blood 
and frozen at a temperature of -80 C until the serum cytokine analysis was performed via 
enzyme-linked immunosorbent assay (ELISA). ELISA kits for each of the cytokines were 
provided by R&D systems, Minneapolis, U.S.A.     
4.3.2 Nerve Conduction Velocity  
 Action potential propagation velocity as well as M-wave amplitude was 
determined by means of a nerve conduction velocity test. Prior to performing the test, the 
electrode locations were prepared by shaving the skin, removing any dead skin cells with 
an abrasive gel, and disinfecting the areas with rubbing alcohol. A surface electrode was 
then coated in an electrolyte gel to create a “bridge” between the electrode and skin 
surface and placed over the motor point of the flexor pollicis brevis. A ground electrode 
was placed over the electrically neutral location of the palm of the hand. The median 
nerve was then stimulated at 2 separate locations at known distances from the recording 
electrode. The median nerve was stimulated at a distal location at the wrist between the 
flexor tendons of the hand. A proximal location was also stimulated at a site just rostral to 
the elbow on the medial side of the biceps brachii. By recording the time taken between 
the initial stimulation and the motor response of the flexor pollicis brevis, and using it in 
conjunction with the known distance traveled, nerve conduction velocity between the two 
stimulation points could be calculated.  
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When electrically evoking an action potential, a standardized set of waveforms 
are displayed by means of an oscilloscope. A short duration spike known as the shock 
artifact represents the initial stimulation of the nerve and a longer duration wave known 
as the M-wave represents the motor response. Therefore, through this visual 
representation of the signal, the time between these two waveforms allows for the 
calculation of the time taken for the impulse to travel the length of the nerve and provides 
the information necessary in the calculation of NCV. A total of 10 trials were taken and 
averaged for each stimulation site. An algorithm was then utilized to accurately identify 
the end of the shock artifact and beginning of the M-wave to be used in the calculation of 
NCV. All data concerning nerve conduction velocity was analyzed via Matlab.  
 
 
 
4.3.3 Muscular Strength  
 A hand dynamometer was used to assess muscular strength. Each subject was 
asked to perform a maximal voluntary contraction by gripping the dynamometer as 
tightly as possible. Force production was recorded, and the highest peak force was taken 
as an indicator of muscular strength (Nicolay & Walker, 2005).   
Figure #1: Distal and Proximal Waveforms (sample data from subject 2 / testing day 2) 
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4.3.4 Muscular Endurance  
 Muscular endurance was also assessed using a hand dynamometer. Each subject 
was asked to maintain a maximum voluntary contraction for 30 seconds. The mean force 
production obtained from the final 5 seconds of the test was then divided by the mean 
force production obtained from the initial 5 seconds of the test. The value obtained was 
taken as an indicator of muscular endurance in which higher values, approaching a score 
of 1, represented greater endurance and fatigue resistance (Nicolay & Walker, 2005).     
4.3.5 Finger Dexterity  
 Two tests were used to determine the level of finger dexterity. The first of which 
was a finger tapping test developed by Kapandji et al. (1986). Subjects were asked to 
perform a predetermined sequence in which the thumb was brought to different regions 
of the four fingers. The sequence consisted of: touching the lateral side of the second 
phalanx of the index finger, the lateral side of the third phalanx of the index finger, the tip 
of the index finger, the tip of the middle finger, the tip of the ring finger, the tip of the 
little finger, the DIP crease of the little finger, the PIP crease of the little finger, the 
proximal crease of the little finger, and finally the distal volar crease of the hand 
(Kapandji, 1986). The time taken to complete an errorless sequence was then recorded as 
an indicator of finger dexterity (see image #2). Subjects then performed a dexterity test 
utilizing the Purdue Pegboard. Each participant was given 30 seconds to place as many 
pegs into the pegboard as possible using only their left hand. The pegs were to be picked 
up and placed one at a time, and the number of pegs successfully placed was used as an 
indicator of dexterity (see image #3).      
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4.4.0 Data Analysis  
 All statistics were calculated using Excel and Statistica. The change in cytokine 
concentrations prior to and following the single bout of treadmill exercise was 
determined using a Student’s t-test. The change in electrophysiological measures, as well 
as the change in grip strength, endurance and finger dexterity was determined via 1-way 
repeated measures ANOVA (with 4 levels for time; pre-exercise as well as 60min, 120 
min, 24hr post-exercise). Pearson’s r correlation analysis was used to determine 
relationships between exercise-induced changes in cytokine concentrations and changes 
in function as well as changes in NCV. Statistical significance was set at p ≤ 0.05 for all 
statistical analyses.     
 
 
 
 
 
 
 
Figure #2: Kapandji Test Figure #3: Purdue Pegboard 
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V. Results  
5.1.0 Exercise Performance  
 
 All subjects successfully completed the 1 hour cycle in its entirety with no 
adverse events. Fluid levels were maintained based on the previously calculated 
estimated fluid loss (see table #1). Following exercise, adequate time was provided for 
body temperature to return to similar levels as seen during initial baseline testing (see 
table #1). 
5.2.0 Cytokine concentrations  
 A Student’s t-test was used to determine if cytokine concentrations were 
significantly different prior to and following a single bout of aerobic exercise by means 
of cycling. Interleukin-10 levels underwent a significant elevation from an average 
resting value of 10.94 ±10.25 pg/ml to an average post-exercise value of 27.52 ± 13.58 
pg/ml (p=0.001, Figure 1a).  Interleukin-1 receptor antagonist was significantly elevated 
with an average resting value of 121.77 ±37.04 pg/ml and an average post-exercise value 
of 210.88 ± 157.52 pg/ml (p=0.051, Figure 1b). Tumour necrosis factor alpha reached 
significantly elevated levels with an average resting value of 5.74 ±5.32 pg/ml and an 
average post-exercise value of 15.99 ±15.89 pg/ml (p=0.031, Figure 1c). Interleukin-6 
was significantly elevated from an average resting value of 6.70 ±7.84 pg/ml to an 
average post-exercise value of 14.27 ±7.14 pg/ml (p=0.018, Figure 1d).     
5.3.0 Nerve Conduction Velocity  
 A repeated measures ANOVA was used to determine if there was a main effect 
for time across four time points including baseline testing, 1 hour post-exercise, 2 hours 
post-exercise, and 24 hours post-exercise. No significant effect was found (F=2.55, 
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p=0.054, Figure 2) and therefore nerve conduction values obtained during baseline 
testing were not found to be significantly different from 1 hour post values, 2 hour post 
values, or 24 hour post values.    
5.4.0 Functional Measures   
A one way repeated measures ANOVA was used to determine if there was a main 
effect for time across each of the four time points for peak force production, endurance, 
and dexterity. No significant main effect was found for peak force production (F=0.437, 
p=0.728, Figure 3), endurance (F=0.841, p=0.482, Figure 4), or dexterity as measured by 
the Kapandji finger tapping test (F=0.636, p=0.598 Figure 5). When measured by means 
of the Purdue pegboard test, a significant main effect for time was found (F=5.15, 
p=0.005, Figure 6). A Tukey’s post analysis revealed significant differences between 
cytokine concentrations at baseline compared to those at 2 hour post-exercise (p=0.004) 
and between cytokine concentrations at 2 hours post-exercise compared to those at 24 
hours post-exercise (p=0.048).     
5.5.0 Correlations  
5.5.1 Interleukin-6 & Nerve Conduction Velocity  
 Pearson’s r correlations were performed to determine if any correlation existed 
between absolute changes in IL-6 concentrations and nerve conduction velocity between 
baseline values and values at 1 hour, 2 hours, and 24 hours post-exercise. A trend was 
also found between the exercise-induced change in IL-6 and the change in NCV from 
baseline to 1 hour post-exercise (r=0.59, p=0.058, Figure 7) such that, the greater the 
increase in IL-6, the greater the increase in NCV. A positive correlation was found 
between the exercise-induced change in IL-6 concentrations and the change in NCV from 
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baseline to 2 hours post-exercise (r=0.61, p=0.048, Figure 8). Relative values were not 
analyzed due to multiple baseline testing IL-6 concentrations equaling 0 pg/ml.    
5.5.2 Interleukin-10 & Nerve Conduction Velocity 
 Pearson’s r correlations were performed to determine if any correlations existed 
between both the absolute and relative change in interleukin-10 concentrations and the 
change in nerve conduction velocity from baseline to 1 hour, 2 hours, and 24 hours post-
exercise. No significant correlations were found between the change in IL-10 
concentrations and the change in NCV at any time point, when examined as either the 
absolute or relative values.  
5.5.3 Interluekin-1 Receptor Antagonist & Nerve Conduction Velocity  
Pearson’s r correlations were performed to determine if any correlations existed 
between both the absolute and relative change in IL-1ra concentrations and the change in 
nerve conduction velocity at 1 hour, 2 hours, and 24 hours post-exercise. A significant 
negative correlation was found between the change in exercised induced change in IL-1ra 
concentrations and the change in NCV from baseline to 24 hours post-exercise when 
examined under both absolute (r=-0.65, p=0.021, Figure 20) and relative (r=-0.60, 
p=0.041, Figure 21) values. Absolute values also yielded trends between the exercise-
induced change IL-1ra concentrations and the change in NCV at 1 hour post-exercise (r=-
0.55, p=0.062, Figure 16) and 2 hours post-exercise (r=-0.48, p=0.11, Figure 18) such 
that, the greater the increase in IL-1ra, the greater the decrease in NCV. Relative values 
also yielded a trend between IL-1ra and NCV at 1 hour post-exercise (r=-0.49, p=0.109, 
Figure 17) such that, the greater the increase in IL-1ra, the greater the decrease in NCV.     
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5.5.4 Tumour Necrosis Factor Alpha & Nerve Conduction Velocity   
Pearson’s r correlations were performed to determine if any correlations existed 
between both the absolute and relative exercise-induced changes in TNF-α concentrations 
and the change in nerve conduction velocity at 1 hour, 2 hours, and 24 hours post-
exercise. No significant correlations were found between the exercise-induced change in 
TNF-α concentrations and the change in NCV at any time points, when examined under 
either absolute or relative values.  
5.5.5 Cytokines & Functional Measures  
 Pearson’s r correlations were performed to determine if any correlations existed 
between both the absolute and relative exercise-induced changes in each of the cytokines 
of interest and each of the functional measures investigated (strength, endurance and 
dexterity of the hand). A trend was found between the absolute exercise-induced change 
in IL-1ra concentrations and the change in handgrip endurance from baseline to 1 hour 
post-exercise (r=0.581, p=0.061, Figure 28). When examined with respect to the relative 
exercise-induced change a significant positive correlation was found between IL-1ra 
concentrations and the change in handgrip endurance (r=0.643, p=0.033, Figure 29) such 
that, the greater the increase in IL-1ra, the greater the increase in endurance scores.   
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VI. Discussion  
6.1.0 Major Findings  
 The current study was the first to examine the potential effects of cytokines on 
peripheral nerve function in humans. The main finding is that two of the cytokines of 
interest were shown to be significantly correlated with alterations in nerve conduction. 
The positive correlation found between IL-6 and nerve conduction velocity approached 
significance 1 hour post-exercise (r=0.586, p=0.058) and achieved significance at 2 hours 
post-exercise (r=0.606, p=0.048). This positive correlation signifies that IL-6 may 
actually act to enhance nerve function as opposed to producing the negative 
channelopathic effects originally hypothesized. The negative correlation found between 
IL-1ra and nerve conduction velocity showed a trend 1 hour post-exercise (r=-0.553, 
p=0.062) and achieved significance 24 hours post-exercise (r=-0.652, p=0.021). This 
negative correlation signifies that IL-1ra may act to slow nerve function through potential 
channelopathic effects previously hypothesized. Interestingly, IL-1ra was also found to 
be positively correlated with endurance scores at 1 hour post-exercise (r=0.643, p=0.033), 
signifying that elevations in IL-1ra may improve muscular endurance despite its negative 
correlation with NCV. The cytokines IL-10 and TNF-α were significantly elevated 
following the exercise intervention but were not correlated with any change in NCV.    
 The potential conduction enhancing properties of IL-6 are novel findings and 
therefore possible mechanisms and rationale for this effect are not available in previous 
literature. However, based on the known response of IL-6 during exercise, it is possible 
to speculate a potential new role in the area of energy regulation. Skeletal muscle has 
been shown to act as an endocrine organ and produce IL-6 at times of an energy crisis 
when muscle glycogen stores become depleted. The secreted IL-6 then acts in a paracrine 
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fashion, stimulating the liver to increase hepatic glucose production and release it into the 
bloodstream, thereby supplying the skeletal muscle with an alternative fuel source 
(Febbraio et al., 2004). Our initial hypothesis that IL-6 would have a detrimental effect 
on NCV seemed fitting as this would imply that IL-6 regulates energy not only by 
controlling for energy production and release, but also by regulating energy usage. A 
decline in nerve conduction would reduce the physical abilities of an individual and help 
to reduce the energy demand to better match that of the available supply. However, as IL-
6 was found to be correlated with a more rapid NCV it may actually be acting in an 
opposing fashion; enhancing nerve conduction to match the newly available supply of 
hepatic glucose. Likewise, it could be acting in a compensatory fashion, enhancing nerve 
function to atone for lower muscle glycogen availability.  
 The mechanism by which IL-6 may increase NCV is also currently unknown. 
However, when comparing IL-6 to other compounds, with more established mechanisms 
for enhancing nerve function, several similarities are apparent. Caffeine is a chemical 
known to enhance alertness and wakefulness. One such proposed mechanism for this is 
caffeine’s ability to block adenosine receptors along the cell surface (Kalmar & Cafarelli, 
1999). Adenosine is a natural by-product of metabolism and acts to reduce the firing rate 
of neurons. By blocking these receptors caffeine prevents these effects and helps to 
increase neuronal firing rate. In addition to an increase in firing rate, the blocking of 
adenosine receptors causes stimulated nerve cells to release the hormone epinephrine. 
This release of epinephrine then acts to increase heart rate and blood flow to skeletal 
muscle, as well as cause the liver to release glucose. IL-6 has been shown to cause the 
release of hepatic glucose as well as the vasodilation of skeletal muscle arterioles which 
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would thereby increase skeletal muscle blood flow (Minghini, Britt, & Hill, 1998). It 
would therefore seem that IL-6 can produce some of the same effects as caffeine, but the 
question remains as to whether it accomplishes these effects through similar mechanisms. 
Interestingly, in a study performed by Minghini et al., it was shown that IL-6 only caused 
vasodilation when performed in vivo. As tests performed in vitro had no vasodilatory 
effects, it can be determined that IL-6 had no direct effects on vascular smooth muscle or 
endothelial cells, but instead must have involved parenchymal or intravascular factors 
(Minghini, Britt, & Hill, 1998). It is possible to speculate then, that IL-6 could in fact be 
causing this vasodilation through its direct effect on neurons, causing the release of 
secondary agents such as epinephrine. Further research is however necessary to establish 
this potential mechanism.  
 The negative correlation found between NCV and IL-1ra is in line with our 
original hypothesis as well as a previous study by Davies et al. (2006), which examined 
the potential effects of cytokines on neural function. Both the current study and that 
performed by Davies et al. (2006), found decreases in NCV when the cytokine of interest 
was at heightened concentrations. The current study differed from the Davies et al. 
(2006) study in several important aspects: i) the effects of a receptor antagonist (IL-1ra) 
rather than a cytokine with both pro and anti-inflammatory properties (TNF-α) was 
examined ii) the effects on peripheral nerves rather than central nerves were examined iii) 
human subjects were used rather than animal tissue iv) testing was performed in vivo, 
rather than ex vivo. The mechanism behind the change in nerve conduction found in these 
two studies may be similar as both showed a significant negative correlation between 
cytokine concentrations and NCV that was reversible. In the study performed by Davies 
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et al. (2006), as well as the present study the reversal of the cytokine-induced effects 
implies that structural damage was not the cause of the reduction in NCV and that an 
alteration in ion channel kinetics as seen in channelopathy was more likely to be the 
causative factor.   
 Despite the significant negative correlation between IL-1ra and NCV, no such 
correlation was found between IL-1ra and peak force production, or dexterity. It would 
therefore seem that although the elevated concentrations of IL-1ra achieved in the current 
study may prove to be adequate to cause reductions in NCV, they are not sufficient to 
translate into losses in the aforementioned functional measures.  A significant positive 
correlation was however found between IL-1ra and muscular endurance. Interestingly, 
this finding suggests an improvement in muscular endurance when IL-1ra levels are 
elevated, despite the fact that elevated levels of IL-1ra were also correlated with reduced 
nerve function. It may be possible that a reduction in the frequency of nerve impulses (as 
caused by IL-1ra) allowed for the muscular contraction to be sustained for a greater 
period of time.      
6.2.0 Clinical / Physiological Significance    
It is important to note that both IL-6 and IL-1ra were successfully elevated to 
levels that closely mimicked those observed following SCI. For example, a study by 
Davies et al. (2007), showed subjects with SCI typically had levels of IL-6 that were 
approximately 3 times higher than healthy able-bodied controls and IL-1ra levels which 
were approximately 2 times higher. The change in TNF-α however, was only elevated 3-
fold, in comparison to an approximately 8-fold increase following SCI. This may explain 
the lack of significant correlations involving TNF-α. The change in IL-10 also differed as 
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the Davies et al. (2007), showed no elevation in IL-10 following SCI whereas our study 
achieved a 3-fold elevation.  
Although IL-1ra was shown to be negatively correlated with NCV and positively 
correlated with endurance, the acute elevation in each cytokine achieved during the 
current study did not appear to have substantial detrimental effects to physical function. It 
is possible however, that had the current study utilized functional measures that were 
more sensitive to small changes in physical function, significant changes could have been 
observed. The fact that IL-6 and IL-1ra were each correlated with NCV would justify 
such a speculation as an alteration in NCV would be expected to have some level of 
influence on function. It also must be taken into consideration that the current study 
observed acute elevations in cytokines, whereas following SCI, acute spikes caused by 
secondary health complications would be tied to a chronic elevation that persist at all 
times. As it is not uncommon for individuals with SCI to suffer from frequent secondary 
health complications, they are often in a state of chronic inflammation (Hayes et al., 
2002). This would make individuals with SCI more susceptible to frequent reductions in 
physical abilities if particular cytokines such as IL-1ra are in fact responsible for 
reductions in NCV. In addition, as the physical abilities of these individuals may already 
be significantly compromised as a direct effect from neuronal damage, even a small drop 
in strength, endurance, or dexterity could have considerable implications. It is therefore 
not justified to conclude that cytokines could not have an effect on physical function 
within this population and future studies may still be warranted to examine this potential.   
In addition to clinical significance, the results have physiological significance due 
to the potential neuromodulatory effects of IL-6. The fact that IL-6 was positively 
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correlated with NCV may indicate a greater role in energy regulation than originally 
believed. In addition to its role in stimulating hepatic glucose production and release, IL-
6 may increase NCV to enhance physical functioning during bouts of exercise. This 
would provide important implications for IL-6 not only in special populations with 
chronically elevated cytokine concentrations, but also in healthy, able-bodied individuals. 
The negative correlation found between IL-1ra and endurance may also indicate an 
exercise related role through its potential effects on nerve function. The positive 
correlation observed between IL-1ra and endurance may be explained by a decrease in 
neuronal firing rate, allowing for force to be maintained for an extended duration.    
Measures of nerve conduction velocity also play an important role as a predictor 
of outcome in the ICU. For example, motor nerve conduction velocity has been shown to 
be a significant mortality risk predictor in hemodialysis patients (Stosovic et al., 2008). 
The fact that disruptions in NCV are associated with higher mortality risks may actually 
be an indicator infection if cytokines are to have detrimental effects to nerve function. 
High levels of infection would invoke highly elevated cytokine levels which could then 
lead to disruptions in nerve signaling.        
6.3.0 Reliability of NCV 
 In order to determine test-retest reliability of the nerve conduction velocity 
measure, the coefficient of variation between the familiarization session and baseline 
testing was calculated. An intra-class correlation coefficient of 0.416 was found. 
However, due to the homogeneity of subject means, resulting in low between-subject 
variability, an examination of the SEM was necessary. Calculation of the SEM resulted in 
a value of 2.87m/s. This value was then divided by the grand mean to calculate a 
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coefficient of variation of 5.19%. This coefficient of variation indicates a desirably low 
variability of NCV between testing days when compared to similar studies involving 
examination of NCV. For example, a study by Lew et al. (2005), examining the NCV on 
the median nerve produced a range of CV’s from 6.1% to 13.4%. 
6.4.0 Reliability and sensitivity of ELISA’s  
 
 In order to assess intra-assay precision between duplicate measures, the 
correlation of variation of each sample was determined. Upon calculation of the 
coefficient of variation it was found that IL-6 had a value of 11%, IL-10 produced a value 
of 21%, IL-1ra produced a value of 22%, and TNF-α produced a value of 29%.  
 The sensitivity of each assay varied between cytokine and was determined by the 
minimum detectable dose (MDD) of the cytokine within the sample. IL-6 had an MDD of 
0.70 pg/ml and IL-10 had an MDD of 3.9 pg/ml. The MDD of both IL-1ra and TNF-α 
ranged in values with IL-1ra falling between 2.15-18.3 pg/ml with a mean MDD of 6.25 
pg/ml, and TNF-α falling between 0.5-5.5 pg/ml with a mean of 1.6 pg/ml.   
6.5.0 Future Directions 
 This study was the first of its kind to examine the potential acute channelopathic 
effects of cytokines on peripheral nerve function, in vivo, using human subjects. Future 
studies that investigate the effects of chronically elevated cytokine levels of nerve 
conduction and functional tasks are also warranted. Such studies would be beneficial as it 
is unknown exactly how long each cytokine would take to ultimately produce its effects 
on neural function. It may therefore be possible to miss the potential channelopathic 
effects of cytokines when examining them under acute conditions.   
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It will also be necessary test a wide variety of cytokines as the current study 
showed that the potential neural effects between cytokines can be highly variable. The 
fact that IL-6 was positively correlated with NCV whereas IL-1ra was negatively 
correlated may signify that certain cytokines may be beneficial to nerve function while 
others are detrimental.  
Similar tests performed on individuals with SCI who are also suffering with some 
form of secondary health complication may also produce valuable findings as it would 
allow for the examination of nerve function while under extremely heightened cytokine 
elevations. This may also produce evidence as to the degree to which particular cytokines 
may affect nerve function and whether or not there is a ceiling effect. For example, if IL-
6 does in fact enhance nerve function as suggested by the current study, it may be 
beneficial to learn by how much this effect is amplified under further heightened IL-6 
levels, at what levels IL-6 ceases to have benefits, and whether extreme elevations can 
actually have negative effects. 
Lastly, future studies may want to examine methods of manipulating cytokine 
concentrations, or limiting their effects. If particular cytokines are found to have harmful 
effects concerning nerve function, methods of lowering chronic elevations, or blocking 
their negative effects could be examined. Likewise, if certain cytokines are found to 
improve nerve function, strategies to enhance their effects or levels while minimizing the 
effects or levels of detrimental cytokines would be ideal.       
6.6.0 Limitations  
 Several limitations were apparent in the current study. First, although the tests 
regarding functional measures were designed to determine if any substantial changes in 
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physical abilities existed, it may have been more appropriate to use more sensitive 
measures. When applying the findings to a special population such as SCI, it is important 
not to disregard small changes in function as even minute changes in strength, endurance, 
and dexterity can have immense implications concerning the ability to perform activities 
of daily living and therefore influence independence and overall quality of life. The use 
of more sensitive measures, particularly concerning the dexterity measurements, may 
have more accurately depicted small changes in function. 
 Second, alterations in NCV may have been more apparent had a longer nerve 
been utilized during testing. The use of a longer nerve within the leg would have forced 
the applied stimulation to travel a greater distance along the channelopathic nerve and 
may have made decreases in NCV more evident. It would however still be necessary to 
test on an inactive limb in order to help control for temperature and local metabolite 
production, so a unique exercise intervention would be necessary.   
 Finally, performing only one pre and post blood draw may have led to less 
accurate quantification of cytokine levels. Due to the fact that cytokine levels naturally 
fluctuate throughout the day, a more accurate measure of basal cytokine concentrations 
may have been possible had multiple pre-exercise blood draws been performed and 
averaged. Pre-blood draws were consistently taken at the same time of day between all 
subjects to help to account for fluctuations, however due to potential differences in sleep 
patterns and diet between subjects, multiple measures may have been beneficial. Multiple 
post blood draws may have also allowed for more accurate quantification of elevated 
cytokine levels. As different cytokines reach peak levels at varying time points following 
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the cessation of exercise, the true peak elevations of certain cytokines may have been 
missed.   
6.7.0 Conclusion 
The current study was the first to examine the acute effects of systemic cytokines 
on peripheral nerve function in humans. The results provided evidence for a potential 
nerve conduction enhancing role of IL-6. This may suggest an even greater role for IL-6 
in energy regulation during exercise than originally believed. The results also provided 
evidence that IL-1ra may produce negative effects on nerve function and reduce NCV. 
The findings of this study warrant further research, potentially examining special 
populations with chronically elevated cytokine concentrations such as those with SCI. 
The fact that such populations have persistent elevations in systemic cytokines on top of 
pre-existing neurological deficits makes spinal cord injured individuals more susceptible 
to the effects of channelopathy.         
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Figure 4: Serum cytokine concentrations prior to and following 1 hour of 
aerobic exercise. Cytokine values are expressed as means ± SD and 
significance was set at p≤0.05. * denotes significant change from pretest 
to posttest as determined by a student’s t-test. 
 
* * 
* 
 
 
68 
 
Nerve Conduction Velocity 
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Figure 5: NCV (m/s) prior to and at a three time points following 1 hour 
of aerobic exercise. NCV values are expressed as means ± SD and 
significance was set at p≤0.05. * denotes significant change between 
NCV values obtained at 2h post-exercise and those obtained at 24h post-
exercise (p=0.017) 
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Figure 6: Peak force production (kg) as measured by grip strength. Peak force 
values are expressed as mean ± SD and significance was set at p≤0.05.    
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Fatigue Index 
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Figure 7: Endurance as assessed by means of 30 second grip strength test. 
Endurance values are expressed as mean ± SD and significance was set at 
p≤0.05. 
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Dexterity Scores (Kapandji Test) 
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Figure 8: Dexterity as assessed by a ten point finger tapping sequence. 
Dexterity values are expressed as mean ± SD and significance was set at 
p≤0.05.    
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Dexterity Scores (Purdue Pegboard Test) 
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* * 
Figure 9: Dexterity as assessed by 30 second peg placement test. Dexterity 
values are expressed as mean ± SD and significance was set at p≤0.05. * 
denotes a significant difference between means such that a significant 
difference was found between pre-exercise and 2h post scores (p=0.003) and 
2h and 24h post scores (p=0.047).     
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IL-6 – NCV Correlation between ΔIL-6 and ΔNCV: Absolute Change 
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Figure 10: Correlation between absolute change of IL-6 and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05. 
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IL-10 – NCV Correlation between ΔIL-10 and ΔNCV: Absolute Change 
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Figure 11: Correlation between absolute change of IL-10 and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05.    
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IL-10 – NCV Correlation between ΔIL-10 and ΔNCV: Relative Change 
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Figure 12: Correlation between relative change of IL-10 and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05.    
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IL-1ra – NCV Correlation between ΔIL-1ra and ΔNCV: Absolute Change 
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Figure 13: Correlation between absolute change of IL-1ra and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05. 
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IL-1ra – NCV Correlation between ΔIL-1ra and ΔNCV: Relative Change 
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Figure 14: Correlation between relative change of IL-1ra and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05. 
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TNF-α – NCV Correlation between ΔTNF-α and ΔNCV: Absolute Change 
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Figure 15: Correlation between absolute change of TNF-α and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05. 
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TNF-α – NCV Correlation between ΔTNF-α and ΔNCV: Relative Change 
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Figure 16: Correlation between absolute change of TNF-α and NCV. A) 
Represents changes 1h post exercise. B) Represents changes 2h post 
exercise. C) Represents changes 24h post exercise. Values are expressed as 
mean ± SD and significance was set at p≤0.05. 
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IL-1ra – Endurance Correlation: 1 Hour Post-exercise (absolute change) 
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Figure 17: Correlation between absolute change of IL-1ra and endurance 1 
hour after the cessation of exercise. Values are expressed as mean ± SD. 
Significance was set at p≤0.05.    
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IL-1ra – Endurance Correlation: 1 Hour Post-exercise (relative change) 
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Figure 18: Correlation between relative change of IL-1ra and endurance 1 
hour after the cessation of exercise. Values are expressed as mean ± SD. 
Significance was set at p≤0.05.    
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Appendix A: Raw Data  
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Table 2: Cytokine concentrations (pg/ml) prior to and following 1 hour of cycling at 65% 
VO2max.  
 
IL-6 IL-10 IL-1ra TNF-alpha 
Subjects Pre Post Pre Post Pre Post Pre Post 
1 25.22 18.0518 4.26 32.57 157.92 182.34 4.76 10.42 
2 0.00 20.67 13.63 21.72 199.34 146.18 7.02 15.63 
3 17.36 11.5752 12.03 49.18 90.55 257.75 6.80 4.76 
4 0.00 16.1226 2.24 42.58 103.22 122.38 4.30 24.46 
5 0.00 8.1991 12.77 23.10 117.13 142.16 6.80 12.46 
6 4.48 19.7054 2.45 19.80 75.41 324.81 9.97 12.68 
7 5.79 9.0948 8.62 38.11 90.24 664.46 15.18 8.83 
8 3.79 14.1245 0.53 8.52 134.75 139.07 3.40 42.13 
9 5.44 6.7522 16.61 12.56 101.99 106.31 0.68 0.00 
10 5.99 4.4096 12.45 26.83 113.42 127.64 1.59 50.28 
11 6.34 28.3179 38.96 43.43 170.90 213.55 12.68 12.91 
12 data removed 6.71 11.92 106.31 103.84 0.00 0.00 
MEAN 6.72 14.27 10.94 27.53 121.77 210.88 5.74 15.99 
SD 7.84 7.14 10.25 13.58 37.04 157.52 5.32 15.89 
 
 
Table 3: Nerve conduction velocity (m/s)  
 
Subjects FAM. Baseline  1h Post 2h Post 24h Post 
1 50.54 52.96 49.14 49.14 50.89 
2 50.93 49.46 53.46 55 53.4 
3 55.21 52.69 53.4 56.2 52.96 
4 56.4 53.88 58.4 59.2 55.6 
5 
Data 
removed 58.41 55.43 60.95 55.63 
6 55.77 61.19 66 64.5 55.65 
7 56.96 64.09 56.3 60.91 55.65 
8 52.03 58.64 59.09 59.32 61.14 
9 54.8 59.57 62.73 62.95 60.68 
10 58.33 54 56.25 56.25 46.07 
11 55.2 50 56.6 54.6 52.88 
12 58.64 55.65 58.18 58.18 56.82 
MEAN 54.98 55.88 57.08 58.10 54.78 
SD 2.76 4.53 4.39 4.18 4.07 
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Table 4: Hand grip force production (kg) 
 
Peak Force Production 
Subject Baseline  1h Post 2h Post 24h Post 
1 48.27 47.13 50.02 48.5 
2 52.24 55.87 52.87 45.97 
3 41.70 46.38 44.50 51.06 
4 55.52 41.78 50.15 52.98 
5 57.32 46.48 51.77 58.77 
6 52.94 49.86 57.21 49.92 
7 44.16 46.65 48.26 46.96 
8 41.43 45.05 44.18 42.89 
9 36.07 39.90 40.71 39.27 
10 49.61 50.44 49.05 40.74 
11 50.18 48.12 46.03 49.32 
12 50.37 57.31 57.42 46.55 
MEAN 48.32 47.99 49.29 47.68 
SD 6.61 5.27 5.32 5.63 
 
 
Table 5: Fatigue Resistance (kg) (final 5 sec / initial 5 sec)  
 
ENDURANCE 
Subject Baseline  1h Post 2h Post 24h Post 
1 0.81 0.76 0.775 0.742 
2 0.736 0.671 0.827 0.818 
3 0.717 0.784 0.67 0.695 
4 0.687 0.666 0.718 0.585 
5 0.818 0.764 0.776 0.872 
6 0.805 0.857 0.76 0.928 
7 0.738 0.796 0.707 0.679 
8 0.786 0.697 0.958 0.951 
9 0.804 0.765 0.77 0.775 
10 0.953 0.724 0.703 0.65 
11 0.797 0.596 0.708 0.689 
12 0.956 0.904 0.691 0.78 
MEAN 0.800 0.748 0.753 0.766 
SD 0.087 0.089 0.082 0.118 
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Table 6: Purdue Pegboard (# of successful pin placements) 
 
DEXTERITY (P.B.) 
Subject Baseline  1h Post 2h Post 24h Post 
1 15.3 16.1 16.2 15.5 
2 14.2 14.4 14.6 14.4 
3 16 16 15.4 15.4 
4 14 13.8 15.8 14.2 
5 14.2 14.8 14.8 15.2 
6 14.6 14.4 16 13.6 
7 13.8 14.8 14.8 14 
8 15.6 15.2 16.4 16.4 
9 16 16.6 17.4 17.4 
10 14.8 15.8 16.2 14.8 
11 14.4 16.2 15.6 15.8 
12 15.4 14.8 16 14.6 
MEAN 14.82 15.16 15.73 15.07 
SD 0.80 0.88 0.82 1.13 
 
 
Table 7: Kapandji Test (time in seconds to complete sequence)  
 
DEXTERITY (K.T.) 
Subject Baseline  1h Post 2h Post 24h Post 
1 3.01 2.84 2.92 2.72 
2 2.85 2.45 2.72 2.69 
3 1.99 2.08 2.04 2.35 
4 2.44 2.47 2.72 2.14 
5 3.04 3.04 2.8 2.9 
6 2.89 2.72 2.48 2.55 
7 3.41 3.18 3.4 2.99 
8 2.7 3.1 3.08 3.07 
9 2.73 2.84 2.5 2.67 
10 3.08 2.85 3.04 2.66 
11 2.77 2.53 2.3 2.49 
12 3.01 2.84 2.84 2.74 
MEAN 2.81 2.74 2.72 2.66 
SD 0.37 0.33 0.38 0.27 
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Appendix B: ANOVA Tables & Correlation Matrices  
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Table 8: Pearson’s r Correlation – Il-6 – NCV (absolute change)   
 
IL-6 Absolute NCV 1h NCV 2h NCV 24h 
r 0.586 0.607 0.440 
r2 0.344 0.368 0.193 
p 0.058 0.048 0.176 
 
 
Table 9: Pearson’s r Correlation – IL-10 – NCV (absolute change)   
 
IL-10 Absolute NCV 1h NCV 2h NCV 24h 
r -0.339 -0.226 -0.257 
r2 0.115 0.051 0.066 
p 0.281 0.481 0.420 
 
 
Table 10: Pearson’s r Correlation – IL-10 – NCV (relative change)   
 
IL-10 Relative NCV 1h NCV 2h NCV 24h 
r -0.091 -0.185 -0.179 
r2 0.008 0.034 0.032 
p 0.779 0.566 0.577 
 
 
Table 11: Pearson’s r Correlation – IL-1ra – NCV (absolute change)   
 
IL-1ra Absolute NCV 1h NCV 2h NCV 24h 
r -0.553 -0.485 -0.652 
r2 0.306 0.235 0.426 
p 0.062 0.110 0.021 
 
 
Table 12: Pearson’s r Correlation – IL-1ra – NCV (relative change)   
 
IL-1ra Relative NCV 1h NCV 2h NCV 24h 
r -0.486 -0.422 -0.595 
r2 0.236 0.178 0.354 
p 0.109 0.172 0.041 
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Table 13: Pearson’s r Correlation – TNF-α – NCV (absolute change)   
 
TNF-alpha Absolute NCV 1h NCV 2h NCV 24h 
r 0.166 0.062 -0.092 
r2 0.028 0.004 0.009 
p 0.606 0.848 0.776 
 
 
Table 14: Pearson’s r Correlation – TNF-α – NCV (relative change)   
 
TNF-alpha Relative NCV 1h NCV 2h NCV 24h 
r 0.074 -0.015 -0.413 
r2 0.006 0.000 0.170 
p 0.818 0.963 0.182 
 
 
Table 15: Pearson’s r Correlation – Il-1ra – Endurance (absolute change)   
 
IL-1ra Absolute ENDURANCE 1h ENDURANCE 2h ENDURANCE 24h 
r 0.581 0.000 0.064 
r2 0.337 0.000 0.004 
p 0.061 0.999 0.852 
 
 
Table 16: Pearson’s r Correlation – Il-1ra – Endurance (relative change)   
 
IL-1ra Relative ENDURANCE 1h ENDURANCE 2h ENDURANCE 24h 
r 0.643 -0.029 0.081 
r2 0.414 0.001 0.007 
p 0.033 0.933 0.813 
 
 
 
